Assessing the Value of Antipsychotics for Treating Schizophrenia: The Importance of Evaluating and Interpreting the Clinical Significance of Individual Service Costs

Author： Tunis S.L.   Ascher-Svanum H.   Stensland M.   Kinon B.J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.1, 2004-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5127-5138

Bentham Science Publishers

Access to resources Recommend Favorite

Rating Scales in Schizophrenia: A Review of Their Usefulness for Assessing Atypical Antipsychotics

By Lader M.  

CNS Drugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 23-32

Adis International

Access to resources Recommend Favorite

Conceptual and Methodological Issues in the Design of Clinical Trials of Antipsychotics for the Treatment of Schizophrenia

By Honer William G.   Thornton Allen E.   Sherwood Megan   MacEwan G. William   Ehmann Tom S.   Williams Richard   Kopala Lili C.   Procyshyn Ric   Barr Alasdair M.  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 699-714

Adis International

Access to resources Recommend Favorite

Antipsychotics for schizophrenia in children and adolescents

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite